Okee Williams

Healthcare, pharma, digital health, health tech, biotech,🏄‍♂️, 🚵🏾‍♂️, 🏔, . Private account & tweets.

[Kavastu @Kavastu]

@samuelmitts Chattat direkt med Niklas nu

[ELEX98 @somchair1]

@MikeNellis You think Tylenol has zero side effects?

[Okee Williams @OkeeWilliams]

@DavidPerlmutter End your social media accounts

[Okee Williams @OkeeWilliams]

@Jurisu Wow!

[Brennan Spiegel, MD, MSHS @BrennanSpiegel]

🩺🤖 New study shows OpenAI's o1 model meets or surpasses human physicians in tackling the toughest diagnostic cases in medicine 🧠📚. It's clear that very soon, *not* using AI could be seen as offering suboptimal care. Full paper here: https://t.co/Q6rOVwlLoR

[Redeye Microcap @microcap_redeye]

Link to report:
https://t.co/aOz1gqS4WC

[Okee Williams @OkeeWilliams]

@andrewpannu @Skhosi1 Can you please DM me as well. Great post.

[Okee Williams @OkeeWilliams]

@paras_biotech Where can I get hold of the report/update

[Paras Sharma @paras_biotech]

XBI's strength many times depends on M&A's momentum - as shown by RBC's analysis below

[Okee Williams @OkeeWilliams]

Dont miss @microcap_redeye Microcap report. Full of interesting data analysis. Free access for now! @Redeye #microcap

[Redeye Microcap @microcap_redeye]

The first Redeye Quality Microcap report was just released.

At 80+ pages, it features commentary on 17 names, an analysis of the Swedish market sentiment, and an interview with none other than @IanCassel.

Available for free using the link below:
https://t.co/IwDI7y1Vtx

[Okee Williams @OkeeWilliams]

Don’t miss Redeye’s latest sector report, Quality Microcap, now available! Also check out our newly released report on SaaS and IT Consulting.

[Redeye @Redeye_]

Redeye provides its first ever sector update for the Swedish microcap space. We introduce the Quality Microcap theme, discuss the 14 target companies in our covered universe and evaluate whether microcaps are set to outperform.

https://t.co/w15YQegub4

[Redeye @Redeye_]

Redeye initiates coverage of Cheffelo, the second-largest provider of meal kits in the Nordic market. As one of the few actors with solid cash generation in an industry seeing investment outflows, Cheffelo holds a strong position.

$CHEF

https://t.co/y6WDihRAlj

[Redeye @Redeye_]

Redeye updates on Calliditas, stating that the company delivered a positive surprise in total sales, including royalty contributions from Asia, US patient enrollment and new subscribers.

$CALTX

https://t.co/veekGNIlfu

[Wolf of X @WolfofX]

A thread on some of the most surreal trains and beautiful train rides

1. The Mauritanian iron ore train, one of the world's longest and heaviest, spans up to 3 km, travels 704 km, and has 200-300 carriages, each weighing up to 84 tons.

[Sports on HBO Max 🇸🇪 @sportshbomaxse]

OS-SEMIFINAL! 🤩🇸🇪 18-åriga Tara Babulfath besegrar världsettan Assunta Scutto i judo.

📲 Streama varje ögonblick från OS i Paris 2024 – bara på Max

[BowTiedBiotech 🧪🔬🧬 @BowTiedBiotech]

2023 Blockbuster Drugs (sales)

Source: Anis Fahandej-Sadi on the HR App!

[Redeye @Redeye_]

Redeye's Growth Day 2024 is LIVE!

Schedule:
09.00-09.20: Cinclus Pharma & Moberg Pharma
09.20-09.40: Active Biotech & Flerie
09.40-10.00: Medivir & Episurf Medical
10.00 - 10.20: Cantargia & Devyser

Tune in:
https://t.co/S7HnDI784w

[Rickard Brånemark @rbranemark]

This is what we do.

[Redeye @Redeye_]

Next up one the Redeye Theme: Commercialization in Life Science event are:

10.50-11:10: Newbury Pharma
11:10-11:30: Xspray Pharma
11:30-11:50: Oncopeptides
11:50-12:10: Xbrane
12:10-12:30: Senzime

Tune in:
https://t.co/cKjQdaKjkG

[Coegin Pharma AB @coeginpharma]

Vår företrädesemission fulltecknades och bolaget tillförs cirka 17,7 MSEK före avdrag för emissionskostnader.

Läs hela PM:et här 👇🏻 https://t.co/VEwHg6J2D3